our study in SMF indicates that female gender has a more indolent disease with a specific phenotype and better prognosis. This finding finally led to a more accurate definition of the natural history of the disease and drove the attention toward a careful interpretation of clinical trial results.
Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project / Barraco D.; Mora B.; Guglielmelli P.; Rumi E.; Maffioli M.; Rambaldi A.; Caramella M.; Komrokji R.; Gotlib J.; Kiladjian J.J.; Cervantes F.; Devos T.; Palandri F.; De Stefano V.; Ruggeri M.; Silver R.T.; Benevolo G.; Albano F.; Merli M.; Pietra D.; Barbui T.; Rotunno G.; Cazzola M.; Giorgino T.; Vannucchi A.M.; Passamonti F.. - In: BLOOD CANCER JOURNAL. - ISSN 2044-5385. - ELETTRONICO. - 8:(2018), pp. 89-92. [10.1038/s41408-018-0128-x]
Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project
Guglielmelli P.;Rotunno G.;Vannucchi A. M.;
2018
Abstract
our study in SMF indicates that female gender has a more indolent disease with a specific phenotype and better prognosis. This finding finally led to a more accurate definition of the natural history of the disease and drove the attention toward a careful interpretation of clinical trial results.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Barraco_BCJ2018.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
424.99 kB
Formato
Adobe PDF
|
424.99 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
